Stephen Horrigan

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Mechanistic basis and efficacy of targeting the β-catenin–TCF7L2–JMJD6–c-Myc axis to overcome resistance to BET inhibitors”.

Mechanistic basis and efficacy of targeting the β-catenin–TCF7L2–JMJD6–c-Myc axis to overcome resistance to BET inhibitors

Blood(2020)10.1182/blood.2019002922

N/A

0DataRank · unranked

73 citations

Warren Fiskus, Christopher P. Mill, Dimuthu Perera, Taghi Manshouri, Bernardo H Lara +18 more

Attenuating nicotine’s effects with high affinity human anti-nicotine monoclonal antibodies

PLoS ONE(2021)10.1371/journal.pone.0254247

N/A

0DataRank · unranked

10 citations

Nicola Beltraminelli, Stephanie Fallot, Mark LeSage, Amy Saykao, Paul R. Pentel +8 more

Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors

PLoS ONE(2022)10.1371/journal.pone.0276047

N/A

0DataRank · unranked

22 citations

Fernanda Costas Casal de Faria, David Koller, Feng Jin, Abeba Zewdu, Gonzalo Lopez +9 more

Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model

Viruses(2022)10.3390/v14102268

N/A

0DataRank · unranked

1 citations

Francesca Curreli, Stephen Horrigan, Andrea Altieri, Alexander V. Kurkin, Asim K. Debnath +1 more

Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression

Leukemia(2023)10.1038/s41375-023-02108-3

N/A

0DataRank · unranked

11 citations

Warren Fiskus, Tapan M. Kadia, Christopher P. Mill, Koji Sasaki, Naval Daver +13 more

Replication-driven HBV cccDNA loss in chimeric mice with humanized livers

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.28.573542

N/A

0DataRank · unranked

3 citations

Yuanping Zhou, B.L. Tempel, Honggang Pan, Stephen Horrigan, Laura Luckenbaugh +4 more

HBVZ10, an AAV8 vector-based new HBV therapy candidate for cccDNA elimination

Molecular Therapy — Methods & Clinical Development(2025)10.1016/j.omtm.2025.101646

N/A

0DataRank · unranked

0 citations

Yuanping Zhou, Stephen Horrigan, Laura Luckenbaugh, Jianming Hu, Fabien Zoulim +2 more